Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729K Buy
3,295
+324
+11% +$79.3K 0.01% 408
2025
Q4
$753K Buy
2,971
+375
+14% +$94.2K 0.01% 399
2025
Q3
$642K Sell
2,596
-87
-3% -$20.8K 0.01% 443
2025
Q2
$645K Buy
2,683
+235
+10% +$54.7K 0.01% 432
2025
Q1
$555K Buy
2,448
+20
+0.8% +$4.4K 0.01% 470
2024
Q4
$499K Sell
2,428
-104
-4% -$22.8K ﹤0.01% 504
2024
Q3
$614K Buy
2,532
+31
+1% +$7.25K 0.01% 465
2024
Q2
$549K Sell
2,501
-929
-27% -$202K 0.01% 458
2024
Q1
$771K Buy
3,430
+1,577
+85% +$356K 0.01% 352
2023
Q4
$407K Sell
1,853
-35
-2% -$7.4K ﹤0.01% 520
2023
Q3
$414K Buy
1,888
+51
+3% +$11.5K ﹤0.01% 488
2023
Q2
$413K Buy
1,837
+263
+17% +$52.6K ﹤0.01% 495
2023
Q1
$301K Sell
1,574
-1
-0.1% -$193 ﹤0.01% 599
2022
Q4
$291K Sell
1,575
-12
-0.8% -$2.11K ﹤0.01% 595
2022
Q3
$264K Sell
1,587
-284
-15% -$57.8K ﹤0.01% 580
2022
Q2
$386K Sell
1,871
-48
-3% -$10.8K 0.01% 481
2022
Q1
$464K Buy
1,919
+32
+2% +$7.42K 0.01% 442
2021
Q4
$459K Buy
1,887
+137
+8% +$31.3K 0.01% 439
2021
Q3
$357K Buy
1,750
+101
+6% +$21.6K ﹤0.01% 518
2021
Q2
$340K Buy
1,649
+104
+7% +$20.9K ﹤0.01% 525
2021
Q1
$294K Buy
1,545
+111
+8% +$20.6K ﹤0.01% 556
2020
Q4
$272K Buy
1,434
+70
+5% +$13.1K ﹤0.01% 491
2020
Q3
$240K Sell
1,364
-20
-1% -$3.2K ﹤0.01% 472
2020
Q2
$212K Sell
1,384
-48
-3% -$7.31K ﹤0.01% 494
2020
Q1
$200K Buy
1,432
+31
+2% +$4.64K ﹤0.01% 431
2019
Q4
$214K Sell
1,401
-73
-5% -$10.7K ﹤0.01% 500
2019
Q3
$213K Buy
1,474
+92
+7% +$13.7K ﹤0.01% 507
2019
Q2
$206K Buy
+1,382
New +$185K ﹤0.01% 501

Other funds holding STE

Greenleaf Trust's STE Position: Q1 2026 in Review

Greenleaf Trust increased its Steris (STE) stake by 11% in Q1 2026, buying an estimated $79.3K and bringing the position to 3,295 shares worth $729K. The position accounts for 0.01% of the portfolio, ranked #408.

Greenleaf Trust first reported a position in STE in Q2 2019 and has held it in 28 quarters since. The position peaked at $771K in Q1 2024. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Greenleaf Trust held 3,295 shares of Steris worth $729K as of Q1 2026.
  • Greenleaf Trust bought 324 Steris shares in Q1 2026, an estimated $79.3K.
  • Steris made up 0.01% of Greenleaf Trust's portfolio in Q1 2026, its #408 holding.
  • Greenleaf Trust first reported a position in Steris in Q2 2019 and has held it in 28 quarters since.
  • Greenleaf Trust's Steris position peaked at $771K in Q1 2024.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.